Iain Martin

1.1k total citations
26 papers, 651 citations indexed

About

Iain Martin is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Iain Martin has authored 26 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 10 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Iain Martin's work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (6 papers) and Neuroscience and Neuropharmacology Research (3 papers). Iain Martin is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (6 papers) and Neuroscience and Neuropharmacology Research (3 papers). Iain Martin collaborates with scholars based in United Kingdom, United States and Sweden. Iain Martin's co-authors include J. Neil Duncan, Martin Smith, Robert J. Riley, Conrad E. Raab, Randy R. Miller, Harold B. Wood, Maria Madeira, Wayne M. Geissler, GT Tucker and Mary L. Williams and has published in prestigious journals such as Journal of Medicinal Chemistry, Carcinogenesis and Drug Discovery Today.

In The Last Decade

Iain Martin

26 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iain Martin United Kingdom 16 235 167 147 138 86 26 651
Bruce W. Surber United States 17 359 1.5× 242 1.4× 238 1.6× 204 1.5× 62 0.7× 36 1.2k
Jennifer L. Liras United States 16 230 1.0× 128 0.8× 186 1.3× 105 0.8× 45 0.5× 21 601
David J. Spalding United Kingdom 13 154 0.7× 100 0.6× 169 1.1× 169 1.2× 81 0.9× 21 579
Kevin N. Dack United Kingdom 12 260 1.1× 221 1.3× 99 0.7× 48 0.3× 34 0.4× 22 683
Nenad Manevski Switzerland 13 258 1.1× 64 0.4× 236 1.6× 189 1.4× 41 0.5× 25 779
Ludy van Beijsterveldt Belgium 11 240 1.0× 102 0.6× 159 1.1× 75 0.5× 84 1.0× 17 620
Simone Braggio Italy 15 214 0.9× 86 0.5× 55 0.4× 57 0.4× 94 1.1× 25 540
Charles D. Thompson United States 18 463 2.0× 164 1.0× 203 1.4× 109 0.8× 268 3.1× 39 877
Rubén Alvarez‐Sánchez Switzerland 15 294 1.3× 94 0.6× 104 0.7× 61 0.4× 62 0.7× 24 728
Randall R. Miller United States 18 409 1.7× 120 0.7× 151 1.0× 249 1.8× 35 0.4× 27 905

Countries citing papers authored by Iain Martin

Since Specialization
Citations

This map shows the geographic impact of Iain Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iain Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iain Martin more than expected).

Fields of papers citing papers by Iain Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iain Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iain Martin. The network helps show where Iain Martin may publish in the future.

Co-authorship network of co-authors of Iain Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Iain Martin. A scholar is included among the top collaborators of Iain Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iain Martin. Iain Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Russell, Laura, Eric Gonzalez, Fabio Broccatelli, et al.. (2020). Advances in the study of drug metabolism – symposium report of the 12th Meeting of the International Society for the Study of Xenobiotics (ISSX). Drug Metabolism Reviews. 52(3). 395–407. 10 indexed citations
2.
Baker, James Α., Michael D. Altman, & Iain Martin. (2018). Interpretation of in Vitro Metabolic Stability Studies for Racemic Mixtures. ACS Medicinal Chemistry Letters. 9(8). 843–847. 2 indexed citations
3.
Martin, Iain, et al.. (2016). A Pharmacokinetic Modeling Approach to Predict the Contribution of Active Metabolites to Human Efficacious Dose. Drug Metabolism and Disposition. 44(8). 1435–1440. 1 indexed citations
4.
Mao, Jialin, Iain Martin, James F. McLeod, et al.. (2016). Perspective: 4β-hydroxycholesterol as an emerging endogenous biomarker of hepatic CYP3A. Drug Metabolism Reviews. 49(1). 18–34. 46 indexed citations
5.
Adam, Julia M., John K. Clark, Takao Kiyoi, et al.. (2012). Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 22(8). 2932–2937. 15 indexed citations
6.
Mete, Antonio, Glen K. Andrews, Stephen Connolly, et al.. (2011). Design of novel and potent cPLA2α inhibitors containing an α-methyl-2-ketothiazole as a metabolically stable serine trap. Bioorganic & Medicinal Chemistry Letters. 21(10). 3128–3133. 4 indexed citations
7.
Cowley, Phillip M., James Α. Baker, John K. Clark, et al.. (2011). Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(7). 2034–2039. 3 indexed citations
8.
Baugh, Mark, David Jonathan Bennett, Jiaqiang Cai, et al.. (2010). 1H-Imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: Separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pka. Bioorganic & Medicinal Chemistry Letters. 21(3). 932–935. 6 indexed citations
9.
Harradine, Paul, et al.. (2010). Control and Measurement of Plasma pH in Equilibrium Dialysis: Influence on Drug Plasma Protein Binding. Drug Metabolism and Disposition. 39(3). 551–557. 25 indexed citations
10.
Ploemen, Jan-Peter H. T. M., et al.. (2007). The Use of Toxicokinetic Data in Preclinical Safety Assessment: A Toxicologic Pathologist Perspective. Toxicologic Pathology. 35(6). 834–837. 9 indexed citations
11.
Baker, James Α., et al.. (2007). The Potential Influence of CO2, as an Agent for Euthanasia, on the Pharmacokinetics of Basic Compounds in Rodents. Drug Metabolism and Disposition. 36(2). 375–379. 19 indexed citations
12.
Walters, Iain A. S., Caroline A. Austin, Rupert P. Austin, et al.. (2007). Evaluation of a series of bicyclic CXCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(2). 798–803. 52 indexed citations
13.
Martin, Iain, Richard J. Lewis, Michael A. Bernstein, et al.. (2006). Which Hydroxy? Evidence for Species Differences in the Regioselectivity of Glucuronidation in Rat, Dog, and Human in Vitro Systems and Dog in Vivo. Drug Metabolism and Disposition. 34(9). 1502–1507. 34 indexed citations
14.
Martin, Iain, et al.. (2003). NMR IDENTIFICATION OF AN S-LINKED GLUCURONIDE OF A TRIAZOLE THIONE FORMED IN VITRO. Drug Metabolism and Disposition. 31(6). 694–696. 9 indexed citations
15.
Riley, Robert J., Iain Martin, & Anne Cooper. (2002). The Influence of DMPK as an Integrated Partner in Modern Drug Discovery. Current Drug Metabolism. 3(5). 527–550. 24 indexed citations
16.
TenBrink, Ruth E., J. Neil Duncan, Douglas W. Harris, et al.. (1996). (S)-(−)-4-[4-[2-(Isochroman-1-yl)ethyl]piperazin-1-yl]benzenesulfonamide, a Selective Dopamine D4 Antagonist. Journal of Medicinal Chemistry. 39(13). 2435–2437. 85 indexed citations
17.
18.
Williams, Mary L., M. S. Lennard, Iain Martin, & GT Tucker. (1994). Interindividual variation in the isomerization of 4- hydroxytamoxifen by human liver microsomes: involvement of cytochromes P450. Carcinogenesis. 15(12). 2733–2738. 38 indexed citations
19.
Speed, William C., Anastasia Parton, Iain Martin, & M. R. Howard. (1994). The use of liquid chromatography/thermospray mass spectrometry with on-line ultraviolet diode array and radiochemical detection: Characterization of the putative metabolites of U-78875 in female rat faeces. Journal of Mass Spectrometry. 23(1). 1–5. 10 indexed citations
20.
Sonesson, Clas, Agneta Ekman, Arvid Carlsson, et al.. (1993). Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[(trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo. Journal of Medicinal Chemistry. 36(22). 3409–3416. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce W. Surber Breakdown of academic impact, for papers by Jennifer L. Liras Breakdown of academic impact, for papers by David J. Spalding Breakdown of academic impact, for papers by Kevin N. Dack Breakdown of academic impact, for papers by Nenad Manevski Breakdown of academic impact, for papers by Ludy van Beijsterveldt Breakdown of academic impact, for papers by Simone Braggio Breakdown of academic impact, for papers by Charles D. Thompson Breakdown of academic impact, for papers by Rubén Alvarez‐Sánchez Breakdown of academic impact, for papers by Randall R. Miller
Rankless by CCL
2026